Pharmaceutical blister package
Latest Warner-Lambert Company Patents:
- Methods of treating neurofibromatosis type 1 with N-((R))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
- Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
- Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
Description
FIG. 1 is a top perspective view of a pharmaceutical blister package showing my new design;
FIG. 2 is a top plan view;
FIG. 3 is an end elevational view thereof; and
FIG. 4 is a side elevational view thereof.
The bottom is plain and unornamented but has the slit seen in FIGS. 1 and 2 .
Referenced Cited
U.S. Patent Documents
Other references
| D201497 | June 1965 | Ninger |
| D237865 | December 1975 | Meierhoefer |
| 3689458 | September 1972 | Hellstrom |
| 3809221 | May 1974 | Compere |
| 3921805 | November 1975 | Compere |
- Modern Packaging, Jun. 1967, p. 135, capsule package.
Patent History
Patent number: D253515
Type: Grant
Filed: May 10, 1977
Date of Patent: Nov 27, 1979
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventor: Eugene J. Meierhoefer (Hackettstown, NJ)
Primary Examiner: Robert C. Spangler
Attorney: Albert H. Graddis
Application Number: 5/795,571
Type: Grant
Filed: May 10, 1977
Date of Patent: Nov 27, 1979
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventor: Eugene J. Meierhoefer (Hackettstown, NJ)
Primary Examiner: Robert C. Spangler
Attorney: Albert H. Graddis
Application Number: 5/795,571
Classifications
Current U.S. Class:
D/9192;
D/9193
International Classification: D0903;
International Classification: D0903;
